Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR | Market Cap | 520.97B |
| Revenue (ttm) | 164.76B |
| Net Income (ttm) | 4.86B |
| Shares Out | 1.33B |
| EPS (ttm) | 3.91 |
| PE Ratio | 99.96 |
| Forward PE | 53.71 |
| Dividend | 0.50 (0.13%) |
| Ex-Dividend Date | Jul 4, 2025 |
| Volume | 3,936,901 |
| Average Volume | 3,699,203 |
| Open | 390.90 |
| Previous Close | 390.40 |
| Day's Range | 388.90 - 392.90 |
| 52-Week Range | 291.00 - 424.95 |
| Beta | 0.24 |
| RSI | 49.88 |
| Earnings Date | Feb 12, 2026 |
About Biocon
Biocon Limited, together with its subsidiaries, manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics, Biosimilars, and Research segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, multiple sclerosis, anti-fungal, anti-cancer, immunosuppressants, and specialty molecules; and biosimilars products consisting of pegfilgrastim, trastuzumab, bevacizumab, a... [Read more]
Financial Performance
In 2024, Biocon's revenue was 152.62 billion, an increase of 3.43% compared to the previous year's 147.56 billion. Earnings were 10.13 billion, a decrease of -0.90%.
Financial StatementsNews
Ajanta Pharma shares jump over 4% after signing in-licensing agreement with Biocon
Shares of Ajanta Pharma Ltd. moved over 4% higher in early trade after the company announced a strategic in-licensing agreement...
Biocon signs out-licensing deal with Ajanta Pharma to market Semaglutide in overseas markets
Biocon Limited has announced the signing of an out-licensing agreement with Ajanta Pharma Ltd for the marketing of its vertically...
Biocon Biologics secures full global rights for Hulio biosimilar Adalimumab
Biocon Biologics Limited, a fully integrated global biosimilars company and subsidiary of Biocon, has announced that it has secured full...
Biocon shares rise jump 2% after US FDA issues VAI status for New Jersey facility
Biocon shares traded higher in early deals after the company announced that it has received an Establishment Inspection Report (EIR)...
Biocon launches Liraglutide for diabetes and obesity in the Netherlands
Biocon Limited, a leading innovation-driven global biopharmaceutical company, has announced the launch of its GLP-1 peptide drug Liraglutide in the...
Bajaj Finance, Biocon & more: Top stocks to buy on December 9 — Check list
JP Morgan maintains a neutral stance on Bajaj Finance, citing strategic growth plans and market share ambitions. Goldman Sachs also holds a neutral rating for Biocon, following its planned integration...
Top stocks to watch today, December 8: Ola Electric, IndiGo, Biocon, Ashoka Buildcon, Cochin Shipyard and more
Benchmark Indian equity indices are expected to begin the week on a muted note as global market signals remain mixed....
Viatris To Sell Equity Stake In Biocon Biologics To Biocon For $815 Mln
(RTTNews) - Viatris Inc. (VTRS) announced that it has entered into definitive agreements with Biocon Limited for the sale of its equity stake in Biocon Biologics Limited. Under the agreements, Biocon ...
Biocon to acquire remaining stake in Biocon Biologics via share swap, valuing it at $5.5 bn
Biocon Limited has approved a major consolidation move, announcing that it will acquire the remaining minority stake in Biocon Biologics...
Biocon Board Approves Capital Expansion, Biocon Biologics Share Acquisition, and Fundraising Plan
Biocon Limited, in its board meeting held on December 06, 2025, approved several major corporate actions, including an increase in...
Biocon Biologics secures market pathway for Denosumab Biosimilars in Europe following settlement with Amgen
Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., announced that it has finalized...
Going bananas for Bengaluru’s road safety: Kiran Mazumdar-Shaw’s compliment sparks buzz on X
Bengaluru: Biocon chief Kiran Mazumdar-Shaw's endorsement of a Kenyan innovation to make flexible, rain-resistant road dividers from compressed banana.
Biocon shares fall sharply over 3% as Citi downgrades stock to ‘Sell’ with target price to Rs 360
Biocon shares slipped more than 3% after Citi downgraded the stock to Sell, citing weakening biosimilar pricing trends, intensifying competition,...
Biocon subsidiary gets U.S. FDA approval for Tofacitinib Extended-Release tablets
Biocon Pharma Limited, a wholly owned arm of Biocon, has received a key regulatory nod from the U.S. Food and...
Biocon clarifies on merger speculation, says committee still evaluating restructuring options
Biocon Limited on Friday, November 14, issued a clarification to the stock exchanges under Regulation 30(11), responding to media reports...
US Proposal Could Halve Biocon's Biosimilar Development Costs
India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more than 60% of its revenue, a top ...
Biocon shares surge over 3% today on strong Q2 performance: Should you buy the stock? — explained
Biocon shares were in focus on Thursday, November 13, rising over 3% to trade near ₹420 after the company posted...
Biocon MD says board has not taken any action on Biocon Biologics merger yet: Report
Biocon Ltd.’s Managing Director said the company’s board has not taken any action yet regarding the potential merger of Biocon...
Stocks to buy today, Nov 13: Honasa, HAL, Tata Steel, Biocon, UPL, Asian Paints, and more among top brokerage recommendations
Brokerages including HSBC, Jefferies, Nomura, Morgan Stanley, CLSA, and Goldman Sachs have released their latest research notes, outlining stock recommendations...
Biocon Ltd (BOM:532523) (HY 2026) Earnings Call Highlights: Strong Growth in Biosimilars and ...
Biocon Ltd (BOM:532523) (HY 2026) Earnings Call Highlights: Strong Growth in Biosimilars and Strategic Partnerships
Half Year 2026 Biocon Ltd Earnings Call Transcript
Half Year 2026 Biocon Ltd Earnings Call Transcript
Stocks in News Today, November 12: Bharat Forge, Waaree Energies, Paras Defence, Biocon, and more
Several stocks are likely to remain in focus in today’s trading session following key corporate announcements, fresh order wins, product...
Top Q2 results today, November 11: Bajaj Finserv, Biocon, Tata Power, RVNL, Hindustan Copper and more to announce earnings
More than 380 listed companies are set to release their July–September quarter (Q2 FY25) financial results today, Tuesday, November 11,...
Biocon shares rise nearly 2% after US FDA moves to ease biosimilar approvals, boosting outlook for Indian biopharma exporters
Biocon shares gained on Thursday, October 30, rising nearly 2% to Rs 380 amid positive sentiment in the biopharmaceutical sector...
After online spat, DK Shivakumar ropes in entrepreneurs to advisory panel on Bengaluru
Bengaluru: Deputy chief minister DK Shivakumar Sunday announced that Biocon chairperson Kiran Mazumdar-Shaw, former Infosys CFO TV Mohandas Pai, and o.